Carl Zeiss Meditec (AFX) Given a €48.00 Price Target at Deutsche Bank

Deutsche Bank set a €48.00 ($57.14) price target on Carl Zeiss Meditec (ETR:AFX) in a research report released on Thursday. The firm currently has a neutral rating on the stock.

AFX has been the subject of a number of other reports. set a €52.00 ($61.90) price objective on shares of Carl Zeiss Meditec and gave the stock a buy rating in a report on Friday, November 10th. Commerzbank set a €42.00 ($50.00) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 8th. Independent Research set a €54.00 ($64.29) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 8th. Berenberg Bank set a €48.00 ($57.14) price objective on shares of Carl Zeiss Meditec and gave the stock a buy rating in a report on Wednesday, September 20th. Finally, Nord/LB set a €60.00 ($71.43) price objective on shares of Carl Zeiss Meditec and gave the stock a buy rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of €50.36 ($59.95).

Carl Zeiss Meditec (ETR:AFX) remained flat at $€53.09 ($63.20) on Thursday. Carl Zeiss Meditec has a twelve month low of €32.14 ($38.26) and a twelve month high of €53.35 ($63.51).

WARNING: This story was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.com-unik.info/2017/12/15/carl-zeiss-meditec-afx-given-a-48-00-price-target-at-deutsche-bank.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

What are top analysts saying about Carl Zeiss Meditec? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Carl Zeiss Meditec and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit